BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31820794)

  • 1. EJP18 peptide derived from the juxtamembrane domain of epidermal growth factor receptor represents a novel membrane-active cell-penetrating peptide.
    Eissa NG; Sayers EJ; Birch D; Patel SG; Tsai YH; Nielsen HM; Jones AT
    Biochem J; 2020 Jan; 477(1):45-60. PubMed ID: 31820794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
    Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ
    J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing tumor-specific intracellular delivering efficiency of cell-penetrating peptide by fusion with a peptide targeting to EGFR.
    Nguyen LT; Yang XZ; Du X; Wang JW; Zhang R; Zhao J; Wang FJ; Dong Y; Li PF
    Amino Acids; 2015 May; 47(5):997-1006. PubMed ID: 25655386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.
    Young Kim H; Young Yum S; Jang G; Ahn DR
    Sci Rep; 2015 Jun; 5():11719. PubMed ID: 26114640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological Correlates.
    Jones S; Uusna J; Langel Ü; Howl J
    Bioconjug Chem; 2016 Jan; 27(1):121-9. PubMed ID: 26623479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular Delivery of DNA and Protein by a Novel Cell-Permeable Peptide Derived from DOT1L.
    Geng J; Guo X; Wang L; Nguyen RQ; Wang F; Liu C; Wang H
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32024261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newly synthesized peptide, Ara-27, exhibits significant improvement in cell-penetrating ability compared to conventional peptides.
    Min S; Kim K; Ku S; Park JY; Seo J; Roh S
    Biotechnol Prog; 2020 Sep; 36(5):e3014. PubMed ID: 32374475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembled peptide nanoparticles for efficient delivery of methotrexate into cancer cells.
    Zakeri-Milani P; Shirani A; Nokhodchi A; Mussa Farkhani S; Mohammadi S; Shahbazi Mojarrad J; Mahmoudian M; Gholikhani T; Farshbaf M; Valizadeh H
    Drug Dev Ind Pharm; 2020 Apr; 46(4):521-530. PubMed ID: 32116040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeras of Cell-Penetrating Peptides Demonstrate Synergistic Improvement in Antisense Efficacy.
    Fadzen CM; Holden RL; Wolfe JM; Choo ZN; Schissel CK; Yao M; Hanson GJ; Pentelute BL
    Biochemistry; 2019 Sep; 58(38):3980-3989. PubMed ID: 31450889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioportides: bioactive cell-penetrating peptides that modulate cellular dynamics.
    Lukanowska M; Howl J; Jones S
    Biotechnol J; 2013 Aug; 8(8):918-30. PubMed ID: 23843291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging.
    Wang W; Abbad S; Zhang Z; Wang S; Zhou J; Lv H
    Curr Cancer Drug Targets; 2015; 15(4):337-51. PubMed ID: 25669720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections.
    Khairkhah N; Namvar A; Bolhassani A
    Mol Biotechnol; 2023 Sep; 65(9):1387-1402. PubMed ID: 36719639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient therapeutic delivery by a novel cell-permeant peptide derived from KDM4A protein for antitumor and antifibrosis.
    Wang H; Ma JL; Yang YG; Song Y; Wu J; Qin YY; Zhao XL; Wang J; Zou LL; Wu JF; Li JM; Liu CB
    Oncotarget; 2016 Aug; 7(31):49075-49090. PubMed ID: 27081693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
    Park SE; Sajid MI; Parang K; Tiwari RK
    Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
    Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
    Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial properties of Latarcin 1 derived cell-penetrating peptides.
    Budagavi DP; Chugh A
    Eur J Pharm Sci; 2018 Mar; 115():43-49. PubMed ID: 29329747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting roles for actin in the cellular uptake of cell penetrating peptide conjugates.
    He L; Sayers EJ; Watson P; Jones AT
    Sci Rep; 2018 May; 8(1):7318. PubMed ID: 29743505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines.
    Patel SG; Sayers EJ; He L; Narayan R; Williams TL; Mills EM; Allemann RK; Luk LYP; Jones AT; Tsai YH
    Sci Rep; 2019 Apr; 9(1):6298. PubMed ID: 31000738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide.
    Lee YW; Hwang YE; Lee JY; Sohn JH; Sung BH; Kim SC
    J Microbiol Biotechnol; 2018 Mar; 28(3):367-374. PubMed ID: 29316746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.